Product Information
MEXILETINE 150 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.2387 per EA under NDC 31722003601. Its NADAC has been published 142 times since Oct 11, 2023.
Strength
150 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722003601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MEXILETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216463On Market Since
11/9/2022
Pharmacological Classes
Price Statistics
The NADAC for MEXILETINE 150 MG CAPSULE has been published 142 times since Oct 11, 2023, and over the history we have for it it has declined 34.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2387 per EA |
|---|---|
| All-time high | $0.4127 (Dec 13, 2023) |
| All-time low | $0.2193 (Jul 17, 2024) |
| 52-week high | $0.2727 |
| 52-week low | $0.2387 |
| Median price | $0.2583 |
| Average price | $0.2801 |
| Largest weekly change | -34.2% (Apr 17, 2024) |
| Weeks tracked | 142 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEXILETINE 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 150 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.2387 per EA (NDC 31722003601), effective Jun 24, 2026.
How has the price of MEXILETINE 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEXILETINE 150 MG CAPSULE has declined 34.1%. It has been tracked across 142 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for MEXILETINE 150 MG CAPSULE?
Since Oct 11, 2023, the NADAC for MEXILETINE 150 MG CAPSULE has ranged from a low of $0.2193 (Jul 17, 2024) to a high of $0.4127 (Dec 13, 2023), with a median of $0.2583 per EA.
Are there cheaper alternatives to MEXILETINE 150 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as MEXILETINE 150 MG CAPSULE, but none are currently priced below it.
Who manufactures MEXILETINE 150 MG CAPSULE?
MEXILETINE 150 MG CAPSULE (NDC 31722003601) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification